Expression of NKG2D and CD107 in CD8 + effector memory lymphocytes in Churg-Strauss syndrome

Clinical and Experimental Rheumatology

Volumn 30, Issue SUPPL. 70, 2012, Pages

  Boita, Monica ^a   Rolla, Giovanni ^a   Mallone, Roberto ^b   Martinuzzi, Emanuela ^c   Heffler, Enrico ^a   Circosta, Paola ^c   Elia, Angela Rita ^c   Cignetti, Alessandro ^c   Caillat Zucman, Sophie ^d   de Menthon, Mathilde ^d   Guida, Giuseppe ^e  

^a UNIVERSITY OF TURIN   (Italy)

^b HÔPITAL SAINT VINCENT DE PAUL   (France)

^c MAURIZIANO HOSPITAL   (Italy)

^d INSERM   (France)

^e ASL TO2   (Italy)

Author keywords

CD8 + T cells; Cytotoxicity; Memory cells; NKG2D; Vasculitis

Indexed keywords

CD28 ANTIGEN; CD45RA ANTIGEN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL KILLER CELL RECEPTOR NKG2D;

ADULT; AGED; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL POPULATION; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD28; ANTIGENS, CD45; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHURG-STRAUSS SYNDROME; E-SELECTIN; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; ITALY; LYMPHOCYTE ACTIVATION; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; PARIS; PHENOTYPE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA;

EID: 84863745508     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. PAGNOUX C, GUILPAIN P, GUILLEVIN L: Churg-Strauss syndrome. Curr Opin Rheumatol 2007; 19: 25-32.
2. JENNETTE JC, FALK RJ, ANDRASSY K et al.: Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
3. VAGLIO A, CASAZZA I, GRASSELLI C, CORRADI D, SINICO RA, BUZIO C: Churg-Strauss syndrome. Kidney Int 2009; 76: 1006-11.
4. SZCZEKLIK W, JAKIEŁA B, ADAMEK D, MUSIAŁ J: Cutting edge issues in the Churg-Strauss syndrome. Clin Rev Allergy Immunol Epub 2011 March 8.
5. DALLOS T, RUIZ HEILAND G, STREHL J et al.: CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum 2010; 62: 3496-503.
6. JAKIELA B, SANAK M, SZCZEKLIK W et al.: Both Th2 and Th17 responses are involved in the pathogenesis of Churg-Strauss syndrome. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S23-34.
7. VAGLIO A, MOOSIG F, ZWERINA J: Churg-Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol 2012; 24: 24-30.
8. KARARIZOU E, DAVAKI P, SPENGOS K, KARANDREAS N, DIMITRACOPOULOS A, VASSILOPOULOS D: Churg-Strauss syndrome complicated by neuropathy: a clinicopathological study of nine cases. Clin Neuropathol 2011; 30: 11-7.
9. + TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome. Clin Immunol 2008; 128: 94-102.
10. ZARITSKAYA L, SHURIN MR, SAYERS TJ, MALYGUINE AM: New flow cytometric assays for monitoring cell-mediated cytotoxicity. Expert Rev Vaccines 2010; 9: 601-16.
11. CHANG MH, KARAGEORGOS LE, MEIKLE PJ: CD107a (LAMP-1) and CD107b (LAMP-2). J Biol Regul Homeost Agents 2002; 16: 147-51.
12. LIEBERMAN J: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003; 3: 361-70.
13. VAN BELLE TL, VON HERRATH MG: The role of the activating receptor NKG2D in autoimmunity. Mol Immunol 2009; 47: 8-11.
14. OBEIDY P, SHARLAND AF: NKG2D and its ligands. Int J Biochem Cell Biol 2009; 41: 2364-7.
15. CAILLAT-ZUCMAN S: How NKG2D ligands trigger autoimmunity? Hum Immunol 2006; 67: 204-7
16. HOLMÉN C, ELSHEIKH E, CHRISTENSSON M et al.: Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis. Am Soc Nephrol 2007; 18: 2497-508.
17. + effector memory T-cells and expression of NKG2Dligand MIC in granulomaous lesions in Wegener's granulomatosis. Clin Immunol 2008; 127: 144-50.
18. MASI AT, HUNDER GG, LIE JT et al.: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.
19. SUPPIAH R, MUKHTYAR C, FLOSSMANN O et al.: A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology 2011; 50: 899-905.
20. SALLUSTO F, LENIG D, FORSTER R, LIPP M, LANZAVECCHIA A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions, Nature 1999; 401: 708-12
21. SALLUSTO F, GEGINAT J, LANZAVECCHIA A: Central memory and effector memory T cell subsets: function, generation, and maintenance, Annu Rev Immunol 2004; 22: 745-63
22. + T-cell memory in tumor immunology and immunotherapy, Immunol Rev 2006; 211: 214-24
23. + T cells. J Exp Med 2001; 194: 1711-9.
24. HIRAYAMA K, ISHIZU T, SHIMOHATA H et al.: Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis. Clin Exp Nephrol 2010; 14: 36-42.
25. HUA F, WILDE B, DOLFF S, WITZKE O: T-lymphocytes and diseasemechanisms in Wegener's granulomatosis. Kidney Blood Press Res 2009; 32: 389-98.
26. + T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 65-78.